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Abstract
Background: Glycemic memory of endothelial cells is an effect of long-lasting hyperglycemia and is a cause of
various diabetics complications, that arises despite of the treatment targeted towards returning low glucose level in
blood system. On the other hand, endothelial dysfunction, which is believed to be a main cause of cardiovascular
complications, is exhibited in the changes of mechanical properties of cells. Although formation of the glycemic
memory was widely investigated, its impact on themechanical properties of endothelial cells has not been studied yet.
Methods: In this study, nanoindentaion with a tip of an atomic force microscope was used to probe the long-term
changes (through 26 passages, c.a. 80 days) in mechanical properties of EA.hy926 endothelial cells cultured in
hyperglycemic conditions. As a complementary method, alterations in the structure of actin cytoskeleton were
visualized by fluorescent staining of F-actin.
Results: We observed a gradual stiffening of the cells up to 20th passage for cells cultured in high glucose (25 mM).
Fluorescence imaging has revealed that this behavior resulted from systematic remodeling of the actin cytoskeleton. In
further passages, a drop in stiffness had occurred. The most interesting finding was recorded for cells transferred after
14 passages from high glucose to normal glucose conditions (5mM). After the transfer, the initial drop in stiffness was
followed by a return of the cell stiffness to the value previously observed for cells cultured constantly in high glucose
Conclusions: Our results indicate that glycemic memory causes irreversible changes in stiffness of endothelial cells.
The formation of the observed “stiffness memory” could be important in the context of vascular complications which
develop despite the normalization of the glucose level.
Keywords: Endothelial cells, Glycemic memory, Cell stiffness, Atomic force microscope, Hyperglycemia,
Cardiovascular complications
Background
Hyperglycemia is one of the main factors, which induce
dysfunction of endothelial cells (ECs). It can lead to an
increase in the permeability of the endothelial mono-
layer and to the development of vascular diseases such as
hypertension, arteriosclerosis or retinopathy [1-3]. In ECs,
contrary to most of other cells, the increased extracellular
glucose level is not accompanied by a decrease in the rate
of glucose transmembrane transport. This mechanism
makes ECs especially sensitive to elevated glucose level
and makes them a major target of hyperglycemia induced
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dysfunction [4]. Increased intracellular glucose concentra-
tion triggers processes specific for oxidative stress and/or
pro-inflammatory state, in particular an increase in the
secretion of mitochondrial reactive oxygen species (ROS)
[5-8]. As described by Yao and Brownlee [6], overpro-
duction of ROS is one of the key steps in the pathogenic
process leading to cardiovascular complications in dia-
betic patients. Consecutive and long-lasting influence of
high glucose (chronic hyperglycemia) on ECs evokes dys-
functional paracrine mechanisms and induces epigenetic
changes that can accelerate cell aging [9-11]. It seems that
such changes cannot be reversed by a simple normaliza-
tion of glucose level. This effect is referred to as glycemic
(or metabolic) memory and is responsible for various
complications in the treatment of diabetic patients. First
findings of glycemic memory were reported over 20 years
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ago and later on confirmed basing on large clinical trials
[2,12,13].
It was postulated that alterations in mechanical prop-
erties of ECs are directly responsible for controlling the
permeability of endothelium and for processes that occur
during shear stress [14]. In particular, a so called stiff
endothelium cell syndrome (SECS) can lead to arte-
rial hypertension and atherosclerosis [15]. In addition,
in recent years, there is a growing number of papers
validating cell stiffness as an indicator of ECs functional
state [16-19]. For example, it has been proven that the
eNOS release is modulated by ECs stiffness, i.e., NO
release follows endothelial nanomechanics, but not vice
versa [18]. Our previous studies on the inflammatory
influence of TNF-α on ECs [19] showed that monitoring
the morphology and nanomechanics of the cells pro-
vides a deep insight into the primary stage of endothelial
dysfunction. Although glycemic memory is extensively
studied at the epigenetic and cellular levels (histonesmod-
ifications and mitochondria metabolism), the long-term
effect of hyperglycemia on cell stiffness has never been
investigated on living cells. To our knowledge, until now
experiments studying hyperglycemia effects on ECs stiff-
ness have been performed only for fixed cells transferred
for measurements to the air conditions [20] and thus such
measurement have a limited bioclinical relevance.
In the presented report we focus on the influence
of chronic hyperglycemic conditions on the mechanical
properties of ECs . In vitro nanoindentation spectroscopy
with an AFM tip was used to characterize the changes in
elastic properties of permanent ECs line (EA.hy926) cul-
tured in high glucose (25 mM - HG) and transferred to
normal (5 mM - NG) glucose concentrations. The main
purpose of this study was to investigate whether glycemic
memory will be reflected in mechanical properties of the
cells transferred to NG culture after long-time exposure
to HG. In order to observe long-term changes in the cell
elasticity, experiments were carried out on the perma-
nent ECs line EA.hy926, which is believed to represent
an adequate cellular model in various diabetic compli-
cations [21]. Moreover, since the dedicated medium for
culturing these cells contains high glucose concentration
[22], this cell line is well suited for studying the chronic
hyperglycemia effects.
Methods
Culture of EA.hy 926
EA.hy 926 is a permanent cell line derived by fusing
human umbilical vein endothelial cells with cell line A549
[23]. The culture was maintained according to the pro-
tocol provided by the distributor of the cell line (ATCC
cat. CRL 2922, Manassas, Virginia, USA). EA.hy926 cells
were cultured in DMEM medium with 25 mM glucose
(HG) supplemented with 10% fetal bovine serum (cat. No
10082-147, Invitrogen), 2 mM L-glutamine, and 2% HAT
supplement (cat. 21060-017, Invitrogen) [22]. After 14
passages (P14 HG), the whole set of cells was divided into
two groups cultured in parallel: the first one was still kept
in the conditions described above; the second one was cul-
tured in DMEM with 5 mM glucose (NG), supplemented
as above.
Sample preparation for stiffness measurements
The glass slides were cleaved into 1 cm x 1 cm plates,
rinsed both sides with ethanol and exposed to UV light
in laminar chamber for 30 min in order to sterilize. Next,
EA.hy926 cells were seeded on the glass slides at density of
104 cells/ml, and cultured to 80% confluence. Afterwards,
the sample was immediately taken for measurements.
Nanoindentationmeasurements using an AFM tip
AFM measurements were performed with a commer-
cial instrument Nanoscope IIIa Multimode SPM (Veeco
Instruments, Santa Barbara, CA, USA). All experiments
were performed on unfixed ECs in DMEM solution using
a commercial fluid chamber (Veeco Instruments). V-
shape gold-coated cantilevers (MLCT multilever, Veeco
Probes, Camarillo, CA, USA) with nominal spring con-
stants of 0.01 N/m were used for nanoindentation mea-
surements. The spring constant of each cantilever was
calculated basing on the thermal oscillations spectrum
analyzed using NanoScope 6.1 software, while the tip
radius was estimated basing on a scan of a test gird
(TGT-1, NT-MDT).
Figure 1A shows the optical image of the monolayer
formed by cells during the experiment. For a given pas-
sage, two samples were examined, about 12-14 cells for
each sample, chosen randomly. The time of characteriza-
tion of each sample was limited to 1.5 h. In the nanoinden-
tation spectroscopy, the AFM tip is attached to a flexible
cantilever and acts as an indenter. Using a piezo-scanner,
a cell placed on a stiff substrate is pushed towards the
tip. This leads to a gentle indentation (deformation) of the
cell. The resulting elastic force (F) applied to the cantilever
(related to its bending) is measured as a function of the
scanner position (z) - this dependence is visualized on a so
called force-distance curve. Later, force-indentation curve
[ F(δz)] is obtained from two separately measured force-
distance curves [ F(z)]. The first force-distance curve,
measured on the cell, contains the information about both
the elastic properties of the cell and the cantilever (see
Figure 1B). Since the AFM hardware only controls the
relative scanner position, the indentation depth δz can-
not be directly determined from a single measurement.
Therefore, for a reference, a second force-distance curve
is measured on a significantly stiffer substrate (glass), for
which the elastic deformation is negligible and the can-
tilever bending is solely determined by the position of the
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Figure 1Methodology of the measurement of elasticity parameter by means of nanoindentation with an AFM tip A) An optical preview
of the sample helps to monitor the experimental conditions and to choose the measurement area over the cell. B) Sample force-distance
curves, 1 - reference curve acquired at a control surface (glass), 2 - force-distance curve taken at the cell. C) The indentation curve obtained on the
basis of 1 and 2. The value of the elasticity parameter is evaluated for each curve, according to the model proposed by Sneddon for a paraboloidal
tip [24].D) Histogram presenting distribution of the elasticity parameter obtained from the analysis of approx. 1200 indentation curves acquired at a
single sample, from multiple cells. The mean value is calculated from the log-normal distribution fit.
piezo-scanner (Figure 1B). Comparison of curves acquired
for the cell and for the stiff substrate allows to obtain the
indentation depth δz and plot the final force-indentation
curve (see Figure 1C). Figure 1D presents histograms of
the elasticity parameter value calculated basing on force-
indentation curves acquired for 8 cells. In order to evalu-
ate the most probable value of the elasticity parameter, a
Log-normal function was fitted to the histogram values.
Actin cytoskeleton imaging
For fluorescence microscopy, cells were seeded on 24-
well plates in the same concentration as described above.
Before staining, the cells were rinsed with pre-warmed
PBS and then fixed with 2.5% formaldehyde for 10 min-
utes. After rinsing them again, cells were permeabilized
with 0.1% Triton X for 4 minutes. Next, cells were incu-
bated in PBS with 1% bovine serum albumin (BSA) for
30 minutes and immediately exposed to phalloidyne con-
jugated with Alexa Fluor (Invitrogen) for 20 minutes.
Prior to the measurement, wells were rinsed twice with
PBS. Images were obtained by Olympus IX71 through
40x objective recorded and processed with Olympus Cell
Sense software. Fluorescence was excited with Olympus
X-Cite Q120 lamp and detected by Olympus U-MWIB2
(Phallodoxine) emission filters.
Results
AFMmeasurements of the cell elasticity parameter
Main motivation of our experiment was to investigate the
elastic properties of EA.hy926 ECs cultured in HG condi-
tions and after the transfer of the cells from HG to NG.
The base culturing medium for this cell line is the high
glucose medium, hence the first part of the experiment
was carried out for cells cultured in HG. Measurements
were continued until the cells incubated in HG conditions
lost the ability to proliferate, which occurred at passage
P26-P27. At the time of half achievable passages - after
P14, we intentionally changed the concentration of HG to
NG for half of the cells, while continuing with HG for the
other half.
The changes of elastic properties for consecutive pas-
sages of EC are presented in Figure 2. Each point on the
graph corresponds to the mean elasticity parameter value
obtained from the analysis of c.a. 1200 indentation curves
(12-14 cells) collected for each passage. Black dots rep-
resent results obtained for cells cultured in HG medium
(glucose concentration 25 mM). There is a distinct stiffen-
ing trend up to P20. It can be observed, that the elasticity
parameter does not increase smoothly, but rather in a
stepwise manner - after each relevant growth in stiffness
(i.e. P4-P7, P10-P13, P14-P16), the value remains similar
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Figure 2 Changes of elasticity parameter for subsequent
passages of the endothelial cells (c.a. 80 days). Results for cells
cultured in HG (25 mM glucose concentration) are marked with black
dots. Red asterisks depict values obtained for cells moved from HG to
NG (5 mM glucose concentration) conditions. Each point on the
graph represents the mean elasticity parameter and error bars
correspond to its standard deviation obtained from the log-normal
distribution fit to approx. 1200 indentation curves.
in the few subsequent passages. In late passages (higher
than P21), the elasticity parameter decreases with time.
After P14, a subpopulation of the cells was transferred
to medium with normal glucose level (NG) (5 mM).
The results of elasticity measurements for those cells are
marked in Figure 2 with red asterisks. Before the trans-
fer to NG conditions, the elasticity parameter value was
(1.24± 0.02) kPa. Initially, the exchange of culturing con-
ditions results in a distinct drop, to (0.88 ± 0.04) kPa,
in elasticity parameter, i.e., cells become softer. However,
maintaining the culture in NG for 4 additional passages
results in the return of the elastic properties to the value
observed before the change of glucose concentration and
very close to the value characteristic for cells cultured
constantly in HG.
The latter observation indicates that culturing the cells
in hyperglycemic environment develops persistent modi-
fication of elastic properties, which cannot be reverted by
a simple decrease in glucose concentration, even to the
physiological level.
Fluorescence imaging
Elasticity measurements were supplemented with fluores-
cent cytoskeleton staining of actin fibers (F-actin). Repre-
sentative images for selected HG passages are presented in
Figure 3: P5 (A), P10 (B), P14 (C). A normal (unchanged)
cytoskeleton structure could be observed in cells cultured
up to 10 subsequent passages in hyperglycemic condi-
tions (Figure 3A). After 14 passages, an increase in the
F-actin content is observed. This indicates that hyper-
glycemia stimulates both polymerization of F-actin and
stress fibers formation. Moreover, it is visible, that after
P14 HG the modification in the structure of the cortical
actin cytoskeleton leads to the intercellular gap forma-
tion and thus to the increase in the permeability of the
endothelium.
After P20 the ECs layer becomes less cohesive and
the integrity of endothelial barrier decreases significantly:
cells are shrunk and numerous gaps between them are
present. As depicted in Figure 2D and 2E, the shape
of cells changes: they become elongated, F-actin fibers
are formed along the cell, across its central part. These
observations are typical for dysfunctional endothelium -
ROS production and activation of intracellular pathways
contributes to the intercellular gaps formation [25]. Low-
ering the glucose concentration to 5 mM after initial 14
passages in HG, caused significant changes in the organi-
zation of cytoskeleton, as presented in Figures 3G-I. Initial
depolymerization of F-actin in (P14+)P2 (Figure 3G) is
reverted in (P14+)P6 (Figure 3F) to the typical HG pat-
tern observed in the passage P20 HG-P24 HG. Such
changes correlate with the changes of elasticity parameter
presented in Figure 2.
Discussion
We investigated the mechanical properties of ECs during
26 subsequent passages (ca. 80 days) in two scenarios: ECs
cultured constantly in hyperglycemic conditions and ECs
reverted to normal glucose level after initial exposition to
high glucose. Our results revealed that long-term influ-
ence of hyperglycemia leads to distinct alterations in the
elastic properties of ECs and in subsequent modifications
of the cellular monolayer. First of all, for ECs incubated
in HG, we observe a stepwise increase in the cell stiffness
up to P20. Literature data unambiguously indicate that
overproduction of mitochondrial ROS is one of the main
factors of hyperglycemia-induced endothelium damage
[5-7,13,26]. On the other hand, it has been well estab-
lished that ROS production decreases the bioavailability
of NO produced by eNOS [13]. Basing on the correla-
tion between NO production and cell stiffness described
in [18,19], we can postulate that elevated ROS produc-
tion in hyperglycemic condition is accompanied by an
increase in ECs stiffness. Moreover, the gradual stiffening
of cells is a reflection of progressive endothelium dysfunc-
tion. The observation discussed above is well supported
by our fluorescence images, that present the structure of
actin cytoskeleton, which is the main parameter deter-
mining the stiffness of cells [15]. For example, the initial
increase in cell stiffness observed with AFM up to P14
is related to the polymerization of actin filaments and
the formation of stress fibers (Figures 3A, B, C). More-
over, it has been shown that the F-actin to G-actin ratio is
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Figure 3 Fluorescent staining of F-actin. Cells cultured in HG medium: P5 (A), P10 (B), P14 (C), P15 (D), P20 (E), P24 (F) and for the cells moved to
NG after 14 passages in hyperglycemic environment (P14+)P2 NG (G), (P14+)P6 NG (H), (P14+)P10 NG (I). The images are organized in such a way,
that images (D), (E), (F) can be easily compared to (G), (H), (I), respectively. Initially, cell present normal structure of actin cytoskeleton (arrow 1).
Later, the polymerization of F-actin leads to stress fibers formation (arrow 2). Additionally, numerous intercellular gaps are formed (arrow 3). Arrow 4
indicate visible actin depolymerization. Images are representative of n=20 independent experiments.
elevated in cells with an increased ROS production [27].
The latter fact supports our conclusion: the changes in
ECs stiffness and F-actin polymerization are related to a
gradual increase in ROS production by cells cultured in
hyperglycemic conditions.
Consequently, for P20 (ECs cultured in HG), a maximal
value of cell stiffness can be observed. After this pas-
sage, a gradual decrease in ECs stiffness took place. Most
likely, this distinct change originates from oxidative stress,
which results in cell damage or in accelerated aging [11].
It was reported, that aged endothelium is characterized by
an increased cell membrane motility and production of a
large number of protrusions or microparticles [28]. The
progressing depolymerization of F-actin, visible in fluo-
rescence images, may be interpreted as a destabilization of
cytoskeleton. We propose, therefore, that the decrease in
stiffness is caused by the oxidative stress.
Now, let us discuss the alterations in elastic properties
of ECs transferred from HG to NG. Initially, after the
switch to NGmedium, the cells rapidly becamemore elas-
tic, from (1.24± 0.02) kPa to (0.88± 0.04) kPa. This quick
response could be attributed to the metabolic shock trig-
gered by lowering glucose concentration. Moreover, the
fluorescence images (Figure 3D and G) show that depoly-
merization process is consistent with our cell stiffness
measurements.
What is even more important, after next 6 passages in
NG medium, the return to the level of stiffness specific
for cells permanently cultured in HG is observed. In other
words, after P20 HG and (P14+)P6 NG, cells show very
similar elastic properties. This means that lowering glu-
cose to the normal level (NG) does not bring the reversal
of the mechanical properties. Hence, we introduce the
term “stiffness memory” as a phenomenon of permanent
change in the mechanical properties of ECs in chronic
hyperglycemia.
Most probably the detected irreversible change in the
elastic properties of ECs is a direct manifestation of
glycemic memory. Hence, stiffness memory, similarly
to glycemic memory, may be related to elevated mito-
chondrial ROS production, which is not inhibited after
glucose normalization. As postulated in [29], chronic
hyperglycemia can modify the function of mitochondria
via glycation of mitochondrial proteins and may induce
prolonged overproduction of mitochondrial ROS.
The phenomenon of stiffness memory enriches the
understanding of vascular complications, which originate
from the glycemic memory. Recently, in a wide review
Jermendy [30] stated that basing on the numerous clini-
cal evidence glycemic memory is considered by clinicians
as an existing phenomenon, not just a hypothesis. The
observed stiffness memory may be a part of the vascu-
lar memory observed in different clinical trials reviewed
in [30].
This work was carried out for a permanent EA.hy926
cell line. Further work on primary EC lines is required
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to get a more detailed insight into the molecular mech-
anism of the stiffness memory effect. It would be also
very interesting to check whether this kind of memory
can be “switched-off” in a similar way as the glycemic
memory effect i.e. by the simultaneous application of
mitochondrial antioxidants (decrease of ROS production)
and reduction of glucose concentration [31].
Conclusions
This report discussed the role of chronic hyperglycemia in
the modification of ECs mechanical properties.It has been
reported previously that increased production of ROS is
the key factor linking hyperglycemia and diabetes compli-
cations. We believe that formation of the stiffness mem-
ory, which alters the global mechanical properties of the
endothelial monolayer, reveals a novel aspect of the phe-
nomenon of the glycemic memory. Our findings underline
the impact of glycemic memory on the mechanical prop-
erties of endothelium with its significant implications
for the development of vascular complications caused by
chronic hyperglycemia.
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